Congressional Stock Trades: Tech Rotations, Healthcare Bets, and Bond Shifts in August 2026 Disclosures
Analysis of recent Congressional stock trades disclosed in August 2026, featuring Big Tech sales, Pfizer moves, and defense ETF shifts by U.S. lawmakers.
By Senate Capitol Research
The mid-August 2026 Congressional stock disclosure window brought a notable flurry of Periodic Transaction Reports (PTRs) submitted under the STOCK Act. Between August 8 and August 15, 2026, disclosures spanning both the House of Representatives and the Senate revealed distinct sector rotations, heavy rebalancings in technology and healthcare, and notable portfolio adjustments in fixed income and exchange-traded funds (ETFs).
While portfolio activity varied from routine rebalancings to substantial single-asset liquidations, several cross-member overlaps—or "Capitol Clusters"—emerged in megacap technology, pharmaceuticals, and industrial commodities.
Big Tech Rotations and Divestments
Technology equities remained a dominant focal point among recent disclosures, though lawmakers displayed contrasting strategies regarding major market leaders.
Apple Inc. (AAPL) Divestment and Trading
Representative Shri Thanedar (D-MI13) reported one of the largest single transaction disclosures of the period, selling between $100,001 and $250,000 worth of Apple Inc. (AAPL) common stock on January 9, 2026 (disclosed August 14, 2026). In addition, Representative Thanedar disclosed a sale of MicroStrategy Inc. (MSTR) valued between $15,001 and $50,000.
Apple also appeared in late-reported filings from Representative Tracey Mann (R-KS01). Filings submitted on August 14, 2026, detailed transactions executed by Rep. Mann’s spouse in August and September 2024, involving small purchases ($1,001–$15,000) and subsequent sales across several tech giants, including Apple (AAPL), NVIDIA (NVDA), Alphabet (GOOGL), Microsoft (MSFT), and Meta Platforms (META).
Active Tech Rebalancing by Rep. Ro Khanna
Representative Ro Khanna (D-CA17) filed an extensive PTR covering dozens of transactions executed in July 2026. Within the technology sector, Rep. Khanna actively added positions in:
- Meta Platforms Inc. (META) ($1,001–$15,000)
- Palantir Technologies Inc. (PLTR) ($1,001–$15,001)
- QUALCOMM Inc. (QCOM) ($1,001–$15,000)
- ServiceNow Inc. (NOW) ($15,001–$50,000)
- Marvell Technology Inc. (MRVL) ($15,001–$50,000)
Simultaneously, Khanna trimmed or exited holdings in Salesforce Inc. (CRM) ($15,001–$50,000) and Autodesk Inc. (ADSK) ($15,001–$50,000), alongside smaller sales in Micron Technology (MU) and Adobe Inc. (ADBE).
Divergent Bets in Healthcare: Pfizer and GE HealthCare
Healthcare stocks provided a striking contrast in sentiment between different Congressional offices, specifically regarding Pfizer Inc. (PFE).
Pfizer Inc. (PFE) Trade Divergence:
---------------------------------------------------------------------
Carol Devine Miller (WV01) | SALE | $15,001 - $50,000
Ro Khanna (CA17) | PURCHASE | $1,001 - $15,000
---------------------------------------------------------------------
- Pfizer Inc. (PFE): Representative Carol Devine Miller (R-WV01) disclosed a spousal sale of Pfizer stock valued between $15,001 and $50,000 (executed March 2025). During the same reporting window, Rep. Ro Khanna disclosed a purchase of Pfizer stock in the $1,001–$15,000 range executed in July 2026.
- GE HealthCare Technologies (GEHC): Rep. Khanna demonstrated repeated accumulation in GE HealthCare, reporting multiple purchases executed in early July 2026, each in the $1,001–$15,000 bracket.
- Broader Healthcare Sales: Rep. Carol Miller’s PTR also reflected spousal liquidations in Quest Diagnostics (DGX) ($15,001–$50,000), while Representative Kevin Hern (R-OK01) reported a joint sale of Organon & Co. (OGN) ($1,001–$15,000).
Industrial Commodities & Fixed Income Realignments
Freeport-McMoRan (FCX) Overlap
A clear Capitol Cluster formed around Freeport-McMoRan Inc. (FCX), a primary global producer of copper and gold, across two different asset classes:
- Senator John Fetterman (D-PA) disclosed the sale of FCX Corporate Bonds valued between $1,001 and $15,000 on July 24, 2026.
- Conversely, Representative Ro Khanna added FCX equity (Stock) in the $1,001–$15,000 bracket on July 7, 2026.
Senator Fetterman’s filing also included a bond sale for toy manufacturer Hasbro Inc. (HAS) ($1,001–$15,000).
Fixed Income Adjustments
Representative William R. Keating (D-MA09) directed capital toward corporate debt, reporting purchases of HCA Healthcare Inc. corporate bonds ($15,001–$50,000) and Capital One Financial Corp. corporate bonds ($1,001–$15,000), both executed on June 30, 2026.